Site Search

Share

X

Search Results

Patient Advocates Send Message to State Leaders: ‘Defend Medicaid Access to Precision Medicine'

Following today’s health-Medicaid budget hearing, more than a dozen cancer survivors and ACS CAN advocates gathered at the New York State Capitol to call on ... took effect, extending biomarker testing access to millions of New Yorkers. The Executive Budget proposal would reverse this gain for health equity by eliminating coverage criteria for Medicaid, potentially jeopardizing coverage for millions of New Yorkers, prompting ... biomarker testing coverage for Medicaid, exclusively, takes aim at the most vulnerable patients who already face countless barriers to their care. As someone who still relies on Medicaid and faces the risk of recurrence, I’m asking lawmakers to reject this proposal outright.”  ACS ...

Cancer Survivors Thank New Mexico State Lawmakers for Passing Biomarker Testing Bill

... the signature of Governor Michelle Lujan Grisham, the bill will expand access to biomarker testing statewide, helping to revolutionize cancer care in New Mexico.  In 2023, more than 11,000 New Mexicans are projected to be diagnosed with cancer and, of those, nearly 3,000 are expected to ... in cancer outcomes by race, ethnicity, income, and geography could increase. Biomarker testing has become a game-changing part of cancer care in recent years as it’s a necessary first step in opening the door to targeted treatments that can lead to survivorship and quality of life. ... are historically marginalized – are being left behind.   “My colleagues in the New Mexico State Legislature have taken a major step toward health equity and improving access to personalized medicine in our state,” said Rep. Joy Garratt, co-sponsor of HB73 and ovarian cancer survivor. ...

Expand Access to Biomarker Testing in Pennsylvania

... partners are working together to make sure more Pennsylvanians can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment. Without action ...

Cancer Patients and Survivors Return to the Capitol to Rally Legislators

... the right time,’ precision medicine has played a critical role in improving cancer outcomes. Passing this legislation would improve access to care and reduce the burden of cancer on Kentuckians.   Roughly 30,270 Kentucky residents will be diagnosed with cancer this year. Having access to ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...

Oncologists to Visit New York State Capitol & Urge Legislators to Improve Access to Biomarker Testing

... – a tool that opens the door to precision medicine.   WHAT:   Improving Access to Biomarker Testing: Opportunity to Revolutionize Cancer Care in New York WHO:   Oncologists, cancer survivors and patient advocates representing ACS CAN to host press conference on biomarker testing ... oncologists and policy experts on how biomarker testing can improve survival outcomes and patients’ quality of life, often with reduced health care costs for the state. Members of the media are invited to attend the press conference and interview volunteers, oncologists and ACS CAN staff ...

Lawmakers Take Critical Step to Revolutionize Cancer Treatment in North Carolina

... the legislation would allow more North Carolinians to access biomarker testing, which has become an increasingly important part of cancer care. Patients who are diagnosed with certain types of cancer can receive biomarker testing to help providers determine the most effective form of ... testing can help save critical time in a cancer fight. This form of precision medicine has become widely used and relied upon in cancer care in recent years, and it’s increasingly important for other disease areas as well. Unfortunately, some people are not benefiting from the ... aligning coverage for biomarker testing with the latest science, we can help increase access to precision medicine that can save lives, improve health outcomes and potentially reduce costs ,” said John Broome , government relations director for the American Cancer Society Cancer Action ...

Time for Mills to Bring Precision Medicine to all Mainers

AUGUSTA – Last week, The Appropriations and Financial Affairs Committee voted to fund LD 1577  An Act to Require Health Insurance Coverage for Biomarker Testing.  This legislation, which passed both House and Senate chambers earlier this month with broad ... first and moved to ensure more Mainers have access to biomarker testing. With this medical advancement, many patients can receive personalized care, specific to their individual disease, that can eliminate unnecessary and costly treatments for some patients. “Now, we’re down to the wire and it’s time to look ahead. After two years of advocacy by public health groups, providers and patients across Maine, the only thing that stands between ensuring insurance coverage of this game changing ...

Final NYS Budget Preserves Biomarker Testing Access

... the precision medicine treatments it unlocks. They bridged divides to deliver for patients and put New York at the forefront of the fight for health care affordability and innovation. Thankfully, lawmakers came back to the table and produced a budget that preserves access to biomarker ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...

ACS CAN Calls for Expanded Access to Biomarker Testing in Washington

... – January 8, 2024 – As Washington legislators convene for the new session, it is crucial for them to prioritize cancer patients and cancer care by assuring all residents have ready access to biomarker testing. "Access to biomarker testing is about identifying the most effective ... Every patient who needs it should have the chance to tap into this vital tool that paves the way for lifesaving treatments." In cancer care, biomarkers are often used to help determine the best treatment for a patient. After a diagnosis, biomarker testing helps connect patients ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...

Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine

... to act on Assembly Bill 1673 / Senate Bill 1196. “In order to maintain our state’s role as a national leader in medical innovation, cancer care and public health, we must prioritize legislation such as Assembly Bill 1673 / Senate Bill 1196. In doing so, we can work to improve health outcomes, patient quality of life and—in some cases—reduce costs. “The victory in Texas should be eye-opening to legislators across ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy